Gender differences in the pharmacology of nicotine addiction

Addiction Biology - Tập 3 Số 4 - Trang 383-404 - 1998
Neal L. Benowitz1, Dorothy K. Hatsukami1
1University of Minnesota, Minneapolis, United States

Tóm tắt

AbstractSmoking rates have declined in recent years less rapidly in women than in men. More adolescent girls than boys are currently smoking. Quitting smoking is reported in many studies to be more difficult in women than in men. These observations suggest that there may be gender differences in the nature of nicotine addiction. Gender differences in various pharmacological processes involved in nicotine addiction are reviewed. Women take in less nicotine from smoking per cigarette than men but, because of slower metabolism, nicotine levels in the body for a given number of cigarettes per day are similar in male and female smokers. Women tend to be less sensitive to the discriminative effects of nicotine and tend to regulate nicotine intake less precisely than men. On the other hand, women appear to be more sensitive to the effects of nicotine in reducing negative affect and reducing body weight. There is a strong association between depression and smoking, and this association appears to be stronger in women than in men. Women tend to respond more to environmental cues associated with smoking than do men. Thus, several lines of evidence suggest that nicotine addiction is different in women than in men. Understanding the basis for gender differences may be of utility in individualizing and optimizing smoking cessation therapy.

Từ khóa


Tài liệu tham khảo

Fiore MC, 1989, Trends in cigarette smoking in the United States. The changing influence of gender and race, J Am Med Assoc, 261, 49, 10.1001/jama.1989.03420010059033

10.1093/oxfordjournals.epirev.a036185

10.1016/S0376-8716(96)01315-4

10.1037/1064-1297.2.3.244

10.1111/j.1360-0443.1994.tb00960.x

10.1046/j.1360-0443.1995.901316.x

10.1136/bmj.309.6958.842

10.2105/AJPH.85.2.223

10.1001/archinte.1993.00410160041003

10.1016/0895-4356(93)90172-W

Department of Health and Human Services PHS., 1988, The health consequences of smoking: nicotine addiction

10.1016/S0025-7125(16)30360-1

10.1146/annurev.pa.36.040196.003121

Henningfield JE, 1995, Psychopharmacology: the fourth generation of progress, 1715

LeHouezec J, 1991, Basic and clinical psychopharmacology of nicotine, Clin Chest Med, 12, 681, 10.1016/S0272-5231(21)00817-0

10.1016/0376-8716(93)90030-T

Benowitz NL., 1990, Research findings on smoking of abused substances, NIDA Research Monograph 99, 12

10.1136/bmj.4.5992.313

10.1007/BF00379078

Benowitz NL, 1990, Nicotine psychopharmacology: molecular, cellular and behavioral aspects, 112, 10.1093/oso/9780192616142.003.0004

10.1093/ajcn/33.1.27

10.1016/0028-3908(72)90045-7

Rosecrans JA, 1972, Brain area nicotine levels in male and female rats of two strains, Arch Int Pharmacodynamie, 196, 46

10.1007/BF00433251

Benowitz NL, 1994, Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine, J Pharmacol Exp Ther, 268, 296

Benowitz NL, 1985, Nicotine renal excretion rate influences nicotine intake during cigarette smoking, J Pharmacol Exp Ther, 234, 153

10.1038/clpt.1994.169

Byrd GD, 1992, Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans‐3′‐hydroxycotinine in smokers, Drug Metab Disp, 20, 192

10.1111/j.2042-7158.1971.tb08770.x

Kyerematen GA, 1988, Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro, Drug Metab Disp, 16, 823

Seaton M, 1991, Nicotine metabolism in stumptailed macaques, Macaca arctoides, Drug Metab Disp, 19, 946

10.1111/j.1600-0773.1969.tb00522.x

Jenner P, 1973, Comparative in vitro hepatic metabolism of some tertiary N‐methyl tobacco alkaloids in various species, Res commun Clin Pathol Pharmacol, 6, 829

10.3109/00498257309151545

10.1038/clpt.1984.67

Moody PM., 1980, The relationships of quantified human smoking behavior and demographic variables, Soc Sci Med, 14, 49

10.1007/BF00435268

10.1016/0306-4603(82)90061-2

10.1016/0091-3057(91)90335-Y

10.1016/0091-3057(95)02034-9

10.1016/0031-9384(94)00320-3

10.1136/bmj.280.6219.972

10.1136/jech.40.1.80

10.1111/j.1360-0443.1993.tb02096.x

10.2105/AJPH.80.9.1053

10.1016/0273-2300(85)90045-5

10.1056/NEJM198307213090303

10.1017/S0033583500004352

Clarke PBS, 1985, Nicotinic binding in rat brain: autoradiographic comparison of [[sup 3]H] acetylcholine, [3H]nicotine and [[sup 125]I] abungarotoxin, J Neurosci, 5, 1307, 10.1523/JNEUROSCI.05-05-01307.1985

10.1146/annurev.ph.57.030195.002513

10.1016/0166-2236(93)90150-K

Collins AC, 1994, Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion, J Pharmacol Exp Ther, 271, 125

10.1111/j.1471-4159.1988.tb10600.x

Breese CR, 1997, Effect of smoking history of [[sup 3]H]nicotine binding in human postmortem brain, J Pharmacol Exp Ther, 282, 7

10.1126/science.7569895

10.1016/0006-8993(94)90401-4

10.1073/pnas.89.20.9949

10.1016/0006-8993(94)91229-7

10.1016/0006-8993(88)91523-5

10.1016/0361-9230(90)90216-M

10.1016/0006-8993(93)91225-H

10.1016/0361-9230(80)90205-1

10.1007/BF00169239

10.1111/j.1365-2826.1989.tb00147.x

10.1007/BF00217067

10.1016/0091-3057(94)90118-X

10.1037/1064-1297.4.2.157

Perkins KA., 1996, Sex differences in nicotine versus non‐nicotine reinforcement as determinants of tobacco smoking, Exp Clin Psychopharmacol, 4, 166, 10.1037/1064-1297.4.2.166

10.1038/clpt.1992.201

10.1007/BF02247470

Perkins KA, 1995, Problems of drug dependence, 288

10.1007/BF02196922

10.1007/BF02247422

Henningfield JE, 1987, Brain reward systems and abuse, 147

Henningfield JE, 1985, Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine, J Pharmacol Exp Ther, 234, 1

10.1016/0306-4530(89)90040-1

10.1007/BF02245082

10.1016/0091-3057(93)90254-Q

10.1016/S0899-3289(94)90253-4

Perkins KA, 1994, Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans, J Pharmacol Exp Ther, 270, 628

10.1016/0091-3057(94)90013-2

10.1111/j.1360-0443.1992.tb03121.x

10.7326/0003-4819-88-1-104

10.1016/0306-4603(81)90050-2

10.1111/j.1469-8986.1987.tb00295.x

10.1016/S0899-3289(18)30008-7

10.1016/0306-4603(83)90035-7

10.1111/j.2044-8260.1971.tb00714.x

10.1037/h0034555

10.1007/BF00846421

10.3109/10826088809039218

10.2307/2344953

10.1093/heapro/7.2.75

10.1111/j.1360-0443.1991.tb01802.x

Solomon LJ, 1993, Nicotine addiction principles and management, 339, 10.1093/oso/9780195064414.003.0017

10.1007/BF02245173

10.1016/0306-4603(84)90018-2

10.1016/0091-3057(92)90531-J

10.1002/hup.470080105

10.1007/BF00427433

10.1037/1064-1297.2.4.345

10.1007/978-1-4899-1669-3_9

10.1037/0278-6133.12.1.24

10.1207/s15324796abm1104_4

10.1037/0021-843X.103.4.801

10.1037/0033-2909.106.2.204

10.1037/0022-006X.59.6.899

10.1056/NEJM199103143241106

10.1001/archfami.1.2.233

10.1037/0022-006X.64.4.799

10.1007/BF00172879

10.1111/j.1360-0443.1992.tb02693.x

10.1002/1098-108X(199409)16:2<177::AID-EAT2260160209>3.0.CO;2-7

10.2105/AJPH.84.11.1818

10.1152/jappl.1992.72.2.401

10.1016/0091-3057(91)90540-I

Perkins KA, 1994, Acute thermogenic effects of nicotine combined with caffeine during light physical activity in male and female smokers, Am J Clin Nutr, 60, 312, 10.1093/ajcn/60.3.312

10.1016/0037-7856(70)90008-9

10.2307/2136415

10.1111/j.1360-0443.1994.tb03738.x

Porchet HC, 1988, Pharmacodynamic model of tolerance: application to nicotine, J Pharmacol Exp Ther, 244, 231

Fattinger K, 1997, Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans, J Pharmacol Exp Ther, 281, 1238

10.1038/clpt.1994.101

10.1038/clpt.1993.27

Department of Health and Human Services PHS., 1990, The health benefits of smoking cessation. A report of the Surgeon General

American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders (DSM‐IV)

Shiffman SM., 1979, National institute on drug abuse monograph

10.1176/ajp.149.4.464

10.2105/AJPH.81.3.324

10.1016/0899-3289(93)90004-U

10.1016/S0899-3289(94)90376-X

10.1016/0306-4603(86)90008-0

10.1016/0306-4603(86)90028-6

10.1016/S0899-3289(10)80024-0

Guilford JS., 1967, Studies and issues in smoking behavior, 95

10.1037/1064-1297.3.2.163

10.1037/0022-006X.58.1.85

10.1016/0306-4603(84)90052-2

Repsher LH., 1994, Smoking cessation by women and older persons: results from the Transdermal Nicotine Study Group, Modern Med, 62, 34

10.1007/BF02439579

10.1016/0306-4603(89)90045-2

10.1016/0306-4530(92)90021-X

10.1016/0306-4603(94)00070-F

10.1016/S0899-3289(96)90170-4

10.3109/10826089209068761

10.1016/0306-4603(89)90001-4

Allen SS, 1991, The shortened premenstrual assessment form, J Reprod Med, 36, 769

10.1016/0091-3057(91)90118-L

10.1016/0306-4603(94)90058-2

American Psychiatric Association, 1987, Diagnostic and statistical manual of mental disorders

10.1001/archpsyc.1991.01810360033005

10.1001/archpsyc.1993.01820130033006

10.1176/ajp.152.3.398

Hall SM, 1993, Nicotine, negative affect and depression, J Consult Clin Psychol, 61, 761, 10.1037/0022-006X.61.5.761

10.1001/jama.1990.03450120058029

10.1001/archpsyc.1993.01820130038007

10.1001/jama.1990.03450120053028

10.1016/0091-7435(88)90061-8

10.2105/AJPH.81.7.859

10.1176/ajp.150.4.546

10.1007/BF02883426

10.1016/0010-440X(90)90042-Q

10.1001/jama.1988.03720190031026

10.1176/ajp.150.10.1546

10.1037/1064-1297.3.4.389

10.1176/ajp.150.6.941

Wilder A., 1965, Narcotics, 85

10.1007/978-1-4613-3626-6_6

10.1037/0033-295X.91.2.251

Rickard‐Figneroa K, 1985, Assessment of smoking urge and its concomitants under an environmental smoking cue manipulation, Addict Behav, 10, 246

10.1016/0306-4603(91)90047-L

10.1037/h0037440

10.1016/0306-4603(91)90054-L

10.1016/0031-9384(85)90341-5

10.1016/0005-7967(88)90003-4

10.1016/0306-4603(89)90029-4

10.1037/1064-1297.3.4.417

10.1111/j.1360-0443.1991.tb01816.x

10.1007/BF00429305

10.1016/0091-3057(85)90572-6

10.1016/0376-8716(93)90065-X

10.1016/S0899-3289(05)80058-6

10.1016/0376-8716(94)90160-0

10.1378/chest.92.6.1005

10.1378/chest.107.5.1358

10.1016/0091-3057(93)90021-K

10.1016/0091-3057(91)90177-4

10.1016/0091-3057(94)00302-Y

10.1007/BF02244919

10.1016/0091-3057(91)90105-B

10.1038/clpt.1993.205

Thông tin
Thông tin xuất bản

Addiction Biology

Tập 3 Số 4

383-404

Thông tin tác giả